Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that PharosAI, a research consortium uniting four leading UK institutions, will use the 10x Genomics Xenium ...

Nucleai, a leader in AI-powered multimodal spatial biology, today announced its contribution to a collaborative international study published in Nature Communications that explores how spatial ...

CHICAGO--(BUSINESS WIRE)-- Bruker Corporation (BRKR) (Nasdaq: BRKR) announced today that it will unveil significant advancements in spatial biology and multiomics research at the 2025 American ...

Researchers have developed two innovative tools to help us delve deeper into cell communication, offering spatial insight ...

Spatial biology first entered the omics scene about a decade ago. Since then, the technology has generated significant buzz both inside and outside of the lab—beyond its contributions to science. The ...

Advancements to include CosMx® Whole Transcriptome Panel; enhanced technology engine to power CellScape™ for spatial proteomics; expansion to 1000-plex protein assay on GeoMx® DSP; and launch of ...

In this article, we examine how multiomics is advancing disease research, particularly in neurodegenerative disorders such as ...

Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global ...

In the rapidly developing field of spatial biology, researchers are working to expand our understanding of biological processes within their spatial context. Scientists are taking a holistic approach ...

Clinical trial data demonstrates how Bio-Techne's spatial biology technology and Nucleai's AI-powered multimodal platforms can identify predictive biomarkers in immunotherapy and targeted ...

Available later this quarter, the commercial CosMx SMI and AtoMx® SIP platforms will be upgraded to an integrated 2.0 software. Following this upgrade, commercial CosMx SMI instruments will deliver up ...